Oncological
Focused ultrasound offers the potential to treat many cancers through noninvasively destroying malignant tissue or enhancing adjuvant therapies, such as chemotherapy, radiation, or immunotherapies.
The technology is approved in Europe and the US to relieve the pain associated with bone metastases and treat prostate diseases including prostate cancer.
Focused ultrasound is also approved in Europe to treat patients with breast, liver, pancreatic and kidney cancers and soft tissue tumors.
In addition, there is significant research activity around the globe assessing the potential of the technology to enhance the delivery and effectiveness of cancer drugs.
Oncological Conditions
- Actinic Keratosis
- Basal Cell Carcinoma
- Biliary Tract Tumors
- Bladder Tumors
- Bone Metastases
- Bone Tumors
- Brain Tumors, Glioma and Metastatic
- Breast Tumors, Malignant
- Cancer Pain
- Cervical Tumors
- Diffuse Intrinsic Pontine Glioma (DIPG)
- Endometrial Tumors
- Esophageal Tumors
- Glioblastoma
- Head and Neck Tumors
- Kidney Tumors
- Liver Tumors
- Lung Tumors
- Melanoma
- Multiple Myeloma
- Multiple Tumors
- Neuroblastoma
- Neurofibromatosis, Type 1 (NF1)
- Ovarian Tumors
- Pancreatic Tumors, Malignant
- Prostate Cancer
- Sacral Chordomas
- Soft Tissue Tumors
- Thyroid Cancer
- Vaginal Tumors